Biotech · Private company · Saint Louis, MO, US
Equator Therapeutics, Inc.
Track this companyFree. Adds Equator Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Partial Agonism of Mitochondrial Thermogenesis for the Safe Stimulation of Energy ExpenditureFiscal year 2026 · $422.8KNIH RePORTER 1R43DK146576-01A1 · fetched Nov 12, 2026
- New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsordersFiscal year 2025 · $1.6MNIH RePORTER 5R44DK127880-03 · fetched Nov 12, 2026
- New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsordersFiscal year 2024 · $1.6MNIH RePORTER 2R44DK127880-02A1 · fetched Nov 12, 2026